Association analysis for the muscarinic M1 receptor genetic polymorphisms and Alzheimer's disease

Dementia and Geriatric Cognitive Disorders
Hsiu-Chih LiuShih-Jen Tsai

Abstract

In the ongoing search to reveal the pathophysiology of Alzheimer's disease (AD), the cholinergic system is important due to its role in cognitive function and its significance with respect to the results of postmortem pathology and animal model studies. For this investigation, we tested the hypothesis that the allelic variant (C267A) of the cholinergic receptor muscarinic 1 (CHRM1) confers susceptibility to AD or is related to its age of onset, in a sample population of 232 AD patients and 169 normal controls. The distribution of the CHRM1 genotypes (p = 0.919) and alleles (p = 0.327) did not differ significantly comparing AD patients and controls, even after stratification according to apolipoprotein E genotype. The onset age was not significantly different comparing the CHRM1 genotype groups. Our negative findings suggest that it is unlikely that the CHRM1 C267A polymorphism plays a substantial role in conferring susceptibility to AD. We propose that other genetic variations of CHRM1, relating either to AD or to the therapeutic response for AD, may need further investigation.

References

Jan 1, 1993·Progress in Brain Research·M R BrannS V Jones
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·J PoirierS Gauthier
Aug 28, 1998·Journal of Neuropathology and Experimental Neurology·C J Ladner, J M Lee
Jul 17, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·K ShiozakiK Kosaka
Sep 6, 2002·Journal of Molecular Neuroscience : MN·William S Messer
Nov 29, 2002·Journal of Neural Transmission. Supplementum·A FisherZ Pittel
Dec 31, 2002·Brain Research·Ezra MulugetaAbdu Adem
Mar 27, 2003·Journal of Neural Transmission·U Finckh
May 24, 2003·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Christoph HockRoger M Nitsch

❮ Previous
Next ❯

Citations

Aug 12, 2014·American Journal of Alzheimer's Disease and Other Dementias·Farhana Ferdous, Keith Diaz Moore
Jul 7, 2005·International Journal of Geriatric Psychiatry
Mar 22, 2020·International Journal of Molecular Sciences·Jia XuQinwen Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.